School of Pharmacy and Biomolecular Sciences, RCSI University of Medicine and Health Sciences, 111 St. Stephen's Green, Dublin 2, Ireland.
Department of Chemistry, RCSI University of Medicine and Health Sciences, 123 St. Stephen's Green, Dublin 2, Ireland.
Molecules. 2021 Jan 8;26(2):301. doi: 10.3390/molecules26020301.
Extemporaneous oral liquid preparations are commonly used when there is no commercially available dosage form for adjustable dosing. In most cases, there is a lack of stability data to allow for an accurately assigned shelf life and storage conditions to give greater confidence of product safety and efficacy over its shelf life. The aim of this study was to evaluate the physical, chemical and microbiological stability of an extemporaneous oral liquid suspension of losartan potassium, 5 mg/mL, used to treat paediatric hypertension in Our Lady's Children's Hospital Crumlin, Ireland. The losartan content of extemporaneous oral suspensions, prepared with and without addition of water, was measured by UV and confirmed by HPLC analysis. Suspensions were stored at 4 °C and room temperature (RT) and were monitored for changes in; pH, colour, odour, re-dispersibility, Total Aerobic Microbial Count, Total Yeast and Mould Count and absence of . Results showed that suspensions prepared by both methods, stored at 4 °C and RT, were physically and microbiologically stable over 28 days. Initial losartan content of all suspensions was lower than expected at 80-81% and did not change significantly over the 28 days. HPLC and NMR did not detect degradation of losartan in the samples. Suspensions prepared in water showed 100% losartan content. The reduced initial losartan content was confirmed by HPLC and was related to the acidic pH of the suspension vehicle. Physiochemical properties of the drug are important factors for consideration in the selection of suspension vehicle for extemporaneous compounding of oral suspensions as they can influence the quality, homogeneity and efficacy of these preparations.
当没有可调节剂量的商业可获得剂型时,通常会使用临时口服液体制剂。在大多数情况下,缺乏稳定性数据来准确分配保质期和储存条件,无法更有信心地确保产品在保质期内的安全性和疗效。本研究的目的是评估爱尔兰克鲁姆林圣母儿童医院用于治疗儿科高血压的 5mg/mL 氯沙坦钾临时口服混悬液的物理、化学和微生物稳定性。通过紫外分光光度法和高效液相色谱分析(HPLC)测量了含有和不含有水的临时口服混悬液中氯沙坦的含量。混悬液在 4°C 和室温下储存,并监测 pH 值、颜色、气味、再分散性、总需氧微生物计数、总酵母菌和霉菌计数以及有无的变化。结果表明,通过两种方法制备的混悬液在 4°C 和室温下储存 28 天,在物理和微生物方面均稳定。所有混悬液的初始氯沙坦含量均低于预期的 80-81%,在 28 天内没有明显变化。HPLC 和 NMR 未检测到样品中氯沙坦的降解。在水中制备的混悬液显示出 100%的氯沙坦含量。初始氯沙坦含量降低通过 HPLC 得到确认,这与混悬剂载体的酸性 pH 值有关。药物的物理化学性质是选择临时配制口服混悬剂的混悬剂载体时需要考虑的重要因素,因为它们会影响这些制剂的质量、均一性和疗效。